OSN [Ossen Innovation] 6-K: (Original Filing)

[Ossen Innovation Announces ADR Ratio Change SHANGHAI, August 16, 2016 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced a ratio change for the Company’s American Depositary Receipt (“ADR”) program. As a result, the number of the] []

OSN [Ossen Innovation] 6-K: Ossen Innovation Announces ADR Ratio Change SHANGHAI, August

[Ossen Innovation Announces ADR Ratio Change SHANGHAI, August 16, 2016 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced a ratio change for the Company’s American Depositary Receipt (“ADR”) program. As a result, the number of the] []

OSN [Ossen Innovation] F-6 POS: ____________________ POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-6

[____________________ POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts ___________________ Ossen Innovation Co., Ltd. (Exact name of issuer of deposited securities as specified in its charter) n/a British Virgin Islands (Jurisdiction of incorporation or organization of issuer) JPMORGAN CHASE BANK, N.A. (Exact name of depositary] [J.P.Morgan AMENDMENT NO. 1, W I T N E S S E T H WHEREAS, the Company and the Depositary executed the Deposit Agreement for the purposes set forth therein; and NOW, THEREFORE, ARTICLE I DEFINITIONS SECTION 1.01. Definitions ARTICLE II AMENDMENTS TO DEPOSIT AGREEMENT AND ADRs SECTION 2.01. SECTION 2.02. SECTION 2.03. 1 SECTION 2.04. ARTICLE III SECTION 3.01.] [Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A. represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Ossen Innovation Co., Ltd., 333-170975) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate the date and]

OSN [Ossen Innovation] 6-K: (Original Filing)

[Ossen Innovation Announces Formation of Special Committee to Evaluate Proposed Transaction SHANGHAI, August 4, 2016 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced that the Company’s Board of Directors, with the unanimous agreement of all directors,] []

OSN [Ossen Innovation] 6-K: Ossen Innovation Announces Formation of Special Committee to

[Ossen Innovation Announces Formation of Special Committee to Evaluate Proposed Transaction SHANGHAI, August 4, 2016 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced that the Company’s Board of Directors, with the unanimous agreement of all directors,] []

OSN [Ossen Innovation] 6-K: (Original Filing)

[Ossen Innovation Enters into Non-Binding Letter of Intent with America-Asia Diabetes Research Upon completion of the Acquisition, the Company would indirectly own 90.27% of San MediTech. San MediTech's proprietary Dynamic Glucose Monitoring System ("DGMS") provides continuous, real-time monitoring of glucose level in diabetes patients, with two patents granted in China and several patents pending both in China and the U.S.] [FORM 6-K OSSEN INNOVATION CO., LTD. 518 SHANGCHENG ROAD, FLOOR 17, SHANGHAI, 200120, PEOPLE’S REPUBLIC OF CHINA Form 20-F x Form 40-F ¨ Yes ¨ No x OSSEN INNOVATION CO., LTD. Number Description 99.1 Press Release, dated July 8, 2016 6-K 1 v443938_6k.htm FORM 6-K]

OSN [Ossen Innovation] 6-K: Ossen Innovation Enters into Non-Binding Letter of Intent

[Ossen Innovation Enters into Non-Binding Letter of Intent with America-Asia Diabetes Research Upon completion of the Acquisition, the Company would indirectly own 90.27% of San MediTech. San MediTech's proprietary Dynamic Glucose Monitoring System ("DGMS") provides continuous, real-time monitoring of glucose level in diabetes patients, with two patents granted in China and several patents pending both in China and the U.S.] [FORM 6-K OSSEN INNOVATION CO., LTD. 518 SHANGCHENG ROAD, FLOOR 17, SHANGHAI, 200120, PEOPLE’S REPUBLIC OF CHINA Form 20-F x Form 40-F ¨ Yes ¨ No x OSSEN INNOVATION CO., LTD. Number Description 99.1 Press Release, dated July 8, 2016 6-K 1 v443938_6k.htm FORM 6-K]

OSN [Ossen Innovation] 6-K: (Original Filing)

[Ossen Innovation Announces First Quarter 2016 Financial Results Earnings Conference Call is Scheduled for 8:30 am ET on June 30, 2016 SHANGHAI, June 29, 2016 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced its financial results] [FORM 6-K OSSEN INNOVATION CO., LTD. 518 SHANGCHENG ROAD, FLOOR 17, SHANGHAI, 200120, PEOPLE’S REPUBLIC OF CHINA Form 20-F x Form 40-F ¨ Yes ¨ No x OSSEN INNOVATION CO., LTD. Number Description 99.1 Press Release, dated June 29, 2016 6-K 1 v443561_6k.htm FORM 6-K]

Skip to toolbar